1073 AZD5863, a CLDN18.2 and CD3 Binding T-cell Engager, Establishes a Multi-Faceted Antitumour Immune Response and Combines Effectively with Chemo-Immunotherapy Regimens
Regular and Young Investigator Award Abstracts(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined